Physician

James Lin, MD

According to 2025 Medicare claims, James Lin, MD (NPI: 1164764544) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is LONG ISLAND VITREO RETINAL CONSULTANTS PC (NPI: 1437262755; TIN: 112566918) and primary practice location at 11788-5100. Lin is affiliated with the Northwell Health ACO (ACO ID: A3030) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,130 traditional Medicare patients, billed 24,040 HCPCS/CPT codes, and received $2,208,366 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 387 prescription claims across 146 beneficiaries totaling $21,883 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 27 records totaling $9,714. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,061 to $2,208,366. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,673 and ending at $21,883. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2017 Medicare payment: $1,061 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,305 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $17,758 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $39,742 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $313,460 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,079,069 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,747,306 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,208,366 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171214$1,061
201895109$4,305
2019172247$17,758
2020206435$39,742
20213971,880$313,460
20226325,662$1,079,069
202390513,512$1,747,306
20241,13024,040$2,208,366

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$63K2015 Drug cost: $5,673 (USD; Tot_Drug_Cst)2016 Drug cost: $32,161 (USD; Tot_Drug_Cst)2017 Drug cost: $63,126 (USD; Tot_Drug_Cst)2018 Drug cost: $4,891 (USD; Tot_Drug_Cst)2019 Drug cost: $6,689 (USD; Tot_Drug_Cst)2020 Drug cost: $27,213 (USD; Tot_Drug_Cst)2021 Drug cost: $57,139 (USD; Tot_Drug_Cst)2022 Drug cost: $24,765 (USD; Tot_Drug_Cst)2023 Drug cost: $16,620 (USD; Tot_Drug_Cst)2024 Drug cost: $21,883 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201537169$5,673
2016144760$32,161
20171981,309$63,126
201866134$4,891
20195087$6,689
202067244$27,213
202192333$57,139
202296269$24,765
2023111299$16,620
2024146387$21,883

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4031,205$106
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more376520$78
92012Established patient problem focused exam of visual system420668$76
92134Imaging of retina1,0032,185$36
92201Extended exam of the back part of the eye with retinal drawing465620$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1014,003$5,269
DifluprednateDifluprednate24579$2,925
Ketorolac TromethamineKetorolac Tromethamine682,380$1,985
OfloxacinOfloxacin581,975$921
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat412,718$791

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$9,714Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James Lin, MD?

Tedicare shows public-source Medicare data for James Lin, MD (NPI 1164764544), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Lin, MD have ACO affiliation data?

James Lin, MD is shown with ACO affiliation data for Northwell Health ACO (MSSP, ACO ID A3030) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to James Lin, MD?

James Lin, MD is linked to LONG ISLAND VITREO RETINAL CONSULTANTS PC (billing NPI 1437262755) in the available physician profile data.

Does James Lin, MD have Open Payments data?

James Lin, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.